WELCHER; Andrew A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for WELCHER; Andrew A..The latest application filed is for "methods of treatment using an interferon gamma inhibitor".

Company Profile

1.16.24

WELCHER; Andrew A. - Ventura CA
Welcher; Andrew A. - Thousand Oaks CA
Welcher; Andrew A. - Glendale CA
Welcher; Andrew A. - New Haven CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treatment Using An Interferon Gamma Inhibitor App 20220144933 - WELCHER; Andrew A. ; et al.	2022-05-12
Methods of treatment using an interferon gamma inhibitor Grant 11,230,597 - Welcher , et al. January 25, 2	2022-01-25
Assay for detecting TH1 and TH2 cell populations Grant 11,156,600 - Gorski , et al. October 26, 2	2021-10-26
Assay for Detecting TH1 and TH2 Cell Populations App 20190219563 - Gorski; Kevin ; et al.	2019-07-18
Assay for detecting Th1 and Th2 cell populations Grant 10,156,562 - Gorski , et al. Dec	2018-12-18
Methods Of Treatment Using An Interferon Gamma Inhibitor App 20180030132 - WELCHER; Andrew A. ; et al.	2018-02-01
Assay for Detecting TH1 and TH2 Cell Populations App 20170082608 - Gorski; Kevin ; et al.	2017-03-23
Methods Of Treatment Using An Interferon Gamma Inhibitor App 20160046709 - WELCHER; ANDREW A. ; et al.	2016-02-18
Human anti-IFN-.gamma. neutralizing antibodies as selective IFN-.gamma. pathway inhibitors Grant 8,906,371 - Welcher , et al. December 9, 2	2014-12-09
Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors App 20140004127 - Welcher; Andrew A. ; et al.	2014-01-02
Methods for treating IFN-.gamma. mediated diseases using human anti-IFN-.gamma. neutralizing antibodies as selective IFN-gamma pathway inhibitors Grant 8,529,893 - Welcher , et al. September 10, 2	2013-09-10
METHODS OF TREATMENT USING AN IFN gamma INHIBITOR App 20130142809 - Welcher; Andrew A. ; et al.	2013-06-06
Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors App 20120269819 - Welcher; Andrew A. ; et al.	2012-10-25
Nucleic acid molecules that encode human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitors Grant 8,202,976 - Welcher , et al. June 19, 2	2012-06-19
Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors App 20110045537 - Welcher; Andrew A. ; et al.	2011-02-24
Human anti-IFN-.gamma. neutralizing antibodies as selective IFN-.gamma. pathway inhibitors Grant 7,790,859 - Welcher , et al. September 7, 2	2010-09-07
Human Anti-ifn-gamma Neutralizing Antibodies As Selective Ifn-gamma Pathway Inhibitors App 20080107655 - Welcher; Andrew A. ; et al.	2008-05-08
Human anti-IFN-.gamma. neutralizing antibodies as selective IFN-.gamma. pathway inhibitors Grant 7,335,743 - Welcher , et al. February 26, 2	2008-02-26
C3b/C4b complement receptor-like molecules and uses thereof App 20060287502 - Welcher; Andrew A. ; et al.	2006-12-21
EPH-like receptor protein tyrosine kinases App 20060216287 - Fox; Gary M. ; et al.	2006-09-28
B7-like molecules and uses thereof App 20060168672 - Welcher; Andrew A. ; et al.	2006-07-27
C3b/C4b Complement Receptor-like molecules and uses thereof Grant 7,041,796 - Welcher , et al. May 9, 2	2006-05-09
C3b/C4b complement receptor-like molecules and uses thereof App 20060030005 - Welcher; Andrew A. ; et al.	2006-02-09
TNFr/OPG-like molecules and uses thereof App 20060024267 - Welcher; Andrew A. ; et al.	2006-02-02
Nucleic acids encoding Eph-like receptor tyrosine kinases Grant 6,992,175 - Fox , et al. January 31, 2	2006-01-31
Human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitors App 20050004353 - Welcher, Andrew A. ; et al.	2005-01-06
Nucleic encoding interleukin-1 receptor antagonist-like proteins and uses thereof App 20040208872 - Welcher, Andrew A. ; et al.	2004-10-21
C3b/C4b complement receptor-like molecules and uses thereof Grant 6,656,707 - Welcher , et al. December 2, 2	2003-12-02
Interleukin-1 receptor antagonist-like molecules and uses thereof App 20030166069 - Welcher, Andrew A. ; et al.	2003-09-04
TNFr/OPG-like molecules and uses thereof App 20030077246 - Welcher, Andrew A. ; et al.	2003-04-24
C3b/C4b complement receptor-like molecules and uses thereof App 20020192758 - Welcher, Andrew A. ; et al.	2002-12-19
Eck receptor ligands Grant 6,479,250 - Bartley , et al. November 12, 2	2002-11-12
C3b/C4b complement receptor-like molecules and uses thereof App 20020151483 - Welcher, Andrew A. ; et al.	2002-10-17
CD20/IgE-receptor like molecules and uses thereof App 20020064823 - Welcher, Andrew A. ; et al.	2002-05-30
EPH-like receptor protein tyrosine kinases Grant 5,981,245 - Fox , et al. No	1999-11-09
Eck receptor ligands Grant 5,716,934 - Bartley , et al. February 10, 1	1998-02-10
RecA nucleoprotein filament and methods Grant 4,888,274 - Radding , et al. December 19, 1	1989-12-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.